Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 1431-39-6 | Product Number: D5405
Dansylamide [for Albumin binding assay]
Purity: >98.0%(T)
- 5-Dimethylaminonaphthalene-1-sulfonamide
| Size | Unit Price | Belgium | Japan* |
Shipping Information
|
|---|---|---|---|---|
| 25MG |
€19.00
|
Contact Us | 29 | |
| 100MG |
€54.00
|
1 | 7 |
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | D5405 |
Purity / Analysis Method
|
>98.0%(T) |
| Molecular Formula / Molecular Weight | C__1__2H__1__4N__2O__2S = 250.32 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Condition to Avoid | Light Sensitive |
Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 1431-39-6 |
| Reaxys Registry Number | 2217203 |
| PubChem Substance ID | 354335223 |
| SDBS (AIST Spectral DB) | 11148 |
| MDL Number | MFCD00004000 |
| Appearance | White to Light yellow powder to crystal |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 218.0 to 222.0 °C |
| Human serum albmin (HSA) binding activity | S/N ratio min. 4 |
| Competitive avtivity in competitive drug | Remaining fluorescein inensity max. 70 % |
| Non-competitive avtivity in non-competitive drug | Remaining fluoresein intensity min. 80 % |
| Melting Point | 219 °C |
| Solubility (soluble in) | Dimethylformamide |
| EC Number | 215-854-1 |
| HS Number | 2935909099 |

References
- 1)The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
- 2)Further Characterization of Specific Drug Binding Sites on Human Serum Albumin
- 3)Fluorescent Dye Cocktail for Multiplex Drug-Site Mapping on Human Serum Albumin
References
- Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism
- A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin
- Structural and functional insights into S-thiolation of human serum albumins
- Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies
- 8‐Prenylnaringenin tissue distribution and pharmacokinetics in mice and its binding to human serum albumin and cellular uptake in human embryonic kidney cells
[Product Highlights] Fluorescent Probe for Human Serum Albumin (HSA)-Drug Binding Assay
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.